Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators..

JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.

2.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators..

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489.

3.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators..

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105. JAMA. 2015 Jun 2;313(21):2185.

4.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators..

N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312.

5.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators., Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

6.

Darapladib for preventing ischemic events in stable coronary heart disease.

STABILITY Investigators., White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L.

N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878.

7.

Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.

Kieval JZ, Karp CL, Abou Shousha M, Galor A, Hoffman RA, Dubovy SR, Wang J.

Ophthalmology. 2012 Mar;119(3):481-6. doi: 10.1016/j.ophtha.2011.08.028.

PMID:
22154538
8.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators..

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819.

9.

Techniques in surface ablation: a comparison of visual outcomes and complications.

Kieval JZ.

Int Ophthalmol Clin. 2011 Spring;51(2):1-10. doi: 10.1097/IIO.0b013e31820f1fff. Review. No abstract available.

PMID:
21383576
10.

Epithelial ingrowth after Descemet stripping automated endothelial keratoplasty: description of cases and assessment with anterior segment optical coherence tomography.

Suh LH, Shousha MA, Ventura RU, Kieval JZ, Perez VL, Wang J, Dubovy SR, Rosenfeld SI, Culbertson WW, Alfonso EC, Forster RK.

Cornea. 2011 May;30(5):528-34. doi: 10.1097/ICO.0b013e3181fb8149.

PMID:
21107249
11.

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.

CURRENT-OASIS 7 Investigators., Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S.

N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475. Erratum in: N Engl J Med. 2010 Oct 14;363(16):1585.

12.

Efficacy of portable X-ray in identifying retained suture needles in ophthalmologic cases.

Kieval JZ, Walsh M, Legutko PA, Daly MK.

Eye (Lond). 2009 Aug;23(8):1731-4. doi: 10.1038/eye.2008.320.

PMID:
18927595
13.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators..

N Engl J Med. 2003 Nov 13;349(20):1893-906. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

14.

Subcellular and subsynaptic localization of presynaptic and postsynaptic kainate receptor subunits in the monkey striatum.

Kieval JZ, Hubert GW, Charara A, Paré JF, Smith Y.

J Neurosci. 2001 Nov 15;21(22):8746-57.

15.

Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia.

Smith Y, Charara A, Paquet M, Kieval JZ, Paré JF, Hanson JE, Hubert GW, Kuwajima M, Levey AI.

J Chem Neuroanat. 2001 Jul;22(1-2):13-42. Review.

PMID:
11470552
16.

Anatomy of the dopamine system in the basal ganglia.

Smith Y, Kieval JZ.

Trends Neurosci. 2000 Oct;23(10 Suppl):S28-33. Review.

PMID:
11052217
18.

CO2 power-assisted hand-held syringe: better visualization during diagnostic and interventional angiography.

Krieger RA, Furst AE, Hildner FJ, Midwall J, Kieval J.

Cathet Cardiovasc Diagn. 1990 Feb;19(2):123-8.

PMID:
2106395
19.

Pulmonic balloon valvuloplasty in adults.

Sherman W, Hershman R, Alexopoulos D, Cohen M, Midwall J, Kieval J, Golinko R.

Am Heart J. 1990 Jan;119(1):186-90. No abstract available.

PMID:
2296858
20.

Failure of Hancock xenograft valve: importance of valve position (4- to 9-year follow-up).

Bolooki H, Mallon S, Kaiser GA, Thurer RJ, Kieval J.

Ann Thorac Surg. 1983 Sep;36(3):246-52.

PMID:
6615061
Items per page

Supplemental Content

Loading ...
Support Center